0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Penem APIs and Intermediates Market Research Report 2026
Published Date: 2026-04-15
|
Report Code: QYRE-Auto-5M17243
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Penem APIs and Intermediates Market Research Report 2024
BUY CHAPTERS

Global Penem APIs and Intermediates Market Research Report 2026

Code: QYRE-Auto-5M17243
Report
2026-04-15
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Penem APIs and Intermediates Market

The global Penem APIs and Intermediates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Penem APIs and Intermediates competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Penem APIs and intermediates are chemical raw materials and drug intermediates used to synthesize penem antibiotics. Penem Antibiotics (Carbapenems) are a class of very effective antibiotic agents most commonly used for treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta-lactam antibiotics drug class, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.
The North American market for Penem APIs and Intermediates is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Penem APIs and Intermediates is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Penem APIs and Intermediates include Shenzhen Haibin Pharmaceutical, Hainan Haiyao, Qilu Antibiotics Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Hisoar Pharmaceutical, Sun Pharmaceutical, Savior Lifetec, ACS Dobfar, Kopran, High Tech Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Penem APIs and Intermediates market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Penem APIs and Intermediates. The Penem APIs and Intermediates market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Penem APIs and Intermediates market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Penem APIs and Intermediates manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Penem APIs and Intermediates Market Report

Report Metric Details
Report Name Penem APIs and Intermediates Market
Segment by Type
  • APIs
  • Intermediates
by Application
  • Meropenem
  • Imipenem
  • Biapenem
  • Ertapenem
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shenzhen Haibin Pharmaceutical, Hainan Haiyao, Qilu Antibiotics Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Hisoar Pharmaceutical, Sun Pharmaceutical, Savior Lifetec, ACS Dobfar, Kopran, High Tech Pharm, Zhuhai United Laboratories, Cspc Holdings, Zhejiang Jiuzhou Pharmaceutical, Jiangxi Fushine Pharmaceutical, Sichuan Xindi Pharmaceutical, Jeil Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Penem APIs and Intermediates manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Penem APIs and Intermediates sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Penem APIs and Intermediates Market report?

Ans: The main players in the Penem APIs and Intermediates Market are Shenzhen Haibin Pharmaceutical, Hainan Haiyao, Qilu Antibiotics Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Hisoar Pharmaceutical, Sun Pharmaceutical, Savior Lifetec, ACS Dobfar, Kopran, High Tech Pharm, Zhuhai United Laboratories, Cspc Holdings, Zhejiang Jiuzhou Pharmaceutical, Jiangxi Fushine Pharmaceutical, Sichuan Xindi Pharmaceutical, Jeil Pharma

What are the Application segmentation covered in the Penem APIs and Intermediates Market report?

Ans: The Applications covered in the Penem APIs and Intermediates Market report are Meropenem, Imipenem, Biapenem, Ertapenem, Others

What are the Type segmentation covered in the Penem APIs and Intermediates Market report?

Ans: The Types covered in the Penem APIs and Intermediates Market report are APIs, Intermediates

1 Penem APIs and Intermediates Market Overview
1.1 Product Definition
1.2 Penem APIs and Intermediates by Type
1.2.1 Global Penem APIs and Intermediates Market Value by Type: 2025 vs 2032
1.2.2 APIs
1.2.3 Intermediates
1.3 Penem APIs and Intermediates by Application
1.3.1 Global Penem APIs and Intermediates Market Value by Application: 2025 vs 2032
1.3.2 Meropenem
1.3.3 Imipenem
1.3.4 Biapenem
1.3.5 Ertapenem
1.3.6 Others
1.4 Global Penem APIs and Intermediates Market Size Estimates and Forecasts
1.4.1 Global Penem APIs and Intermediates Revenue 2021–2032
1.4.2 Global Penem APIs and Intermediates Sales 2021–2032
1.4.3 Global Penem APIs and Intermediates Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Penem APIs and Intermediates Market Competition by Manufacturers
2.1 Global Penem APIs and Intermediates Sales Market Share by Manufacturers (2021–2026)
2.2 Global Penem APIs and Intermediates Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Penem APIs and Intermediates Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Penem APIs and Intermediates, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Penem APIs and Intermediates, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Penem APIs and Intermediates, Product Types and Applications
2.7 Global Key Manufacturers of Penem APIs and Intermediates, Date of Entry into the Industry
2.8 Global Penem APIs and Intermediates Market Competitive Situation and Trends
2.8.1 Global Penem APIs and Intermediates Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Penem APIs and Intermediates Players Market Share by Revenue
2.8.3 Global Penem APIs and Intermediates Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Penem APIs and Intermediates Market Scenario by Region
3.1 Global Penem APIs and Intermediates Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Penem APIs and Intermediates Sales by Region: 2021–2032
3.2.1 Global Penem APIs and Intermediates Sales by Region: 2021–2026
3.2.2 Global Penem APIs and Intermediates Sales by Region: 2027–2032
3.3 Global Penem APIs and Intermediates Revenue by Region: 2021–2032
3.3.1 Global Penem APIs and Intermediates Revenue by Region: 2021–2026
3.3.2 Global Penem APIs and Intermediates Revenue by Region: 2027–2032
3.4 North America Penem APIs and Intermediates Market Facts & Figures by Country
3.4.1 North America Penem APIs and Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Penem APIs and Intermediates Sales by Country (2021–2032)
3.4.3 North America Penem APIs and Intermediates Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Penem APIs and Intermediates Market Facts & Figures by Country
3.5.1 Europe Penem APIs and Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Penem APIs and Intermediates Sales by Country (2021–2032)
3.5.3 Europe Penem APIs and Intermediates Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Penem APIs and Intermediates Market Facts & Figures by Region
3.6.1 Asia Pacific Penem APIs and Intermediates Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Penem APIs and Intermediates Sales by Region (2021–2032)
3.6.3 Asia Pacific Penem APIs and Intermediates Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Penem APIs and Intermediates Market Facts & Figures by Country
3.7.1 Latin America Penem APIs and Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Penem APIs and Intermediates Sales by Country (2021–2032)
3.7.3 Latin America Penem APIs and Intermediates Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Penem APIs and Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Penem APIs and Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Penem APIs and Intermediates Sales by Country (2021–2032)
3.8.3 Middle East and Africa Penem APIs and Intermediates Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Penem APIs and Intermediates Sales by Type (2021–2032)
4.1.1 Global Penem APIs and Intermediates Sales by Type (2021–2026)
4.1.2 Global Penem APIs and Intermediates Sales by Type (2027–2032)
4.1.3 Global Penem APIs and Intermediates Sales Market Share by Type (2021–2032)
4.2 Global Penem APIs and Intermediates Revenue by Type (2021–2032)
4.2.1 Global Penem APIs and Intermediates Revenue by Type (2021–2026)
4.2.2 Global Penem APIs and Intermediates Revenue by Type (2027–2032)
4.2.3 Global Penem APIs and Intermediates Revenue Market Share by Type (2021–2032)
4.3 Global Penem APIs and Intermediates Price by Type (2021–2032)
5 Segment by Application
5.1 Global Penem APIs and Intermediates Sales by Application (2021–2032)
5.1.1 Global Penem APIs and Intermediates Sales by Application (2021–2026)
5.1.2 Global Penem APIs and Intermediates Sales by Application (2027–2032)
5.1.3 Global Penem APIs and Intermediates Sales Market Share by Application (2021–2032)
5.2 Global Penem APIs and Intermediates Revenue by Application (2021–2032)
5.2.1 Global Penem APIs and Intermediates Revenue by Application (2021–2026)
5.2.2 Global Penem APIs and Intermediates Revenue by Application (2027–2032)
5.2.3 Global Penem APIs and Intermediates Revenue Market Share by Application (2021–2032)
5.3 Global Penem APIs and Intermediates Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shenzhen Haibin Pharmaceutical
6.1.1 Shenzhen Haibin Pharmaceutical Company Information
6.1.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.1.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.2 Hainan Haiyao
6.2.1 Hainan Haiyao Company Information
6.2.2 Hainan Haiyao Description and Business Overview
6.2.3 Hainan Haiyao Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hainan Haiyao Penem APIs and Intermediates Product Portfolio
6.2.5 Hainan Haiyao Recent Developments/Updates
6.3 Qilu Antibiotics Pharmaceutical
6.3.1 Qilu Antibiotics Pharmaceutical Company Information
6.3.2 Qilu Antibiotics Pharmaceutical Description and Business Overview
6.3.3 Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.3.5 Qilu Antibiotics Pharmaceutical Recent Developments/Updates
6.4 Zhejiang Hisun Pharmaceutical
6.4.1 Zhejiang Hisun Pharmaceutical Company Information
6.4.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.4.3 Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.4.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.5 Zhejiang Hisoar Pharmaceutical
6.5.1 Zhejiang Hisoar Pharmaceutical Company Information
6.5.2 Zhejiang Hisoar Pharmaceutical Description and Business Overview
6.5.3 Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.5.5 Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Company Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Savior Lifetec
6.7.1 Savior Lifetec Company Information
6.7.2 Savior Lifetec Description and Business Overview
6.7.3 Savior Lifetec Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Savior Lifetec Penem APIs and Intermediates Product Portfolio
6.7.5 Savior Lifetec Recent Developments/Updates
6.8 ACS Dobfar
6.8.1 ACS Dobfar Company Information
6.8.2 ACS Dobfar Description and Business Overview
6.8.3 ACS Dobfar Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ACS Dobfar Penem APIs and Intermediates Product Portfolio
6.8.5 ACS Dobfar Recent Developments/Updates
6.9 Kopran
6.9.1 Kopran Company Information
6.9.2 Kopran Description and Business Overview
6.9.3 Kopran Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kopran Penem APIs and Intermediates Product Portfolio
6.9.5 Kopran Recent Developments/Updates
6.10 High Tech Pharm
6.10.1 High Tech Pharm Company Information
6.10.2 High Tech Pharm Description and Business Overview
6.10.3 High Tech Pharm Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 High Tech Pharm Penem APIs and Intermediates Product Portfolio
6.10.5 High Tech Pharm Recent Developments/Updates
6.11 Zhuhai United Laboratories
6.11.1 Zhuhai United Laboratories Company Information
6.11.2 Zhuhai United Laboratories Description and Business Overview
6.11.3 Zhuhai United Laboratories Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zhuhai United Laboratories Penem APIs and Intermediates Product Portfolio
6.11.5 Zhuhai United Laboratories Recent Developments/Updates
6.12 Cspc Holdings
6.12.1 Cspc Holdings Company Information
6.12.2 Cspc Holdings Description and Business Overview
6.12.3 Cspc Holdings Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Cspc Holdings Penem APIs and Intermediates Product Portfolio
6.12.5 Cspc Holdings Recent Developments/Updates
6.13 Zhejiang Jiuzhou Pharmaceutical
6.13.1 Zhejiang Jiuzhou Pharmaceutical Company Information
6.13.2 Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
6.13.3 Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.13.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
6.14 Jiangxi Fushine Pharmaceutical
6.14.1 Jiangxi Fushine Pharmaceutical Company Information
6.14.2 Jiangxi Fushine Pharmaceutical Description and Business Overview
6.14.3 Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.14.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates
6.15 Sichuan Xindi Pharmaceutical
6.15.1 Sichuan Xindi Pharmaceutical Company Information
6.15.2 Sichuan Xindi Pharmaceutical Description and Business Overview
6.15.3 Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.15.5 Sichuan Xindi Pharmaceutical Recent Developments/Updates
6.16 Jeil Pharma
6.16.1 Jeil Pharma Company Information
6.16.2 Jeil Pharma Description and Business Overview
6.16.3 Jeil Pharma Penem APIs and Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Jeil Pharma Penem APIs and Intermediates Product Portfolio
6.16.5 Jeil Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Penem APIs and Intermediates Industry Chain Analysis
7.2 Penem APIs and Intermediates Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Penem APIs and Intermediates Production Mode & Process Analysis
7.4 Penem APIs and Intermediates Sales and Marketing
7.4.1 Penem APIs and Intermediates Sales Channels
7.4.2 Penem APIs and Intermediates Distributors
7.5 Penem APIs and Intermediates Customer Analysis
8 Penem APIs and Intermediates Market Dynamics
8.1 Penem APIs and Intermediates Industry Trends
8.2 Penem APIs and Intermediates Market Drivers
8.3 Penem APIs and Intermediates Market Challenges
8.4 Penem APIs and Intermediates Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Penem APIs and Intermediates Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Penem APIs and Intermediates Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Penem APIs and Intermediates Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Penem APIs and Intermediates Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Penem APIs and Intermediates Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Penem APIs and Intermediates Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Penem APIs and Intermediates Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Penem APIs and Intermediates Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Penem APIs and Intermediates, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Penem APIs and Intermediates, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Penem APIs and Intermediates, Product Types and Applications
 Table 12. Global Key Manufacturers of Penem APIs and Intermediates, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Penem APIs and Intermediates Companies by Tier (Tier 1, Tier 2, Tier 3), based on Penem APIs and Intermediates Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Penem APIs and Intermediates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Penem APIs and Intermediates Sales by Region (Tons), 2021–2026
 Table 18. Global Penem APIs and Intermediates Sales Market Share by Region (2021–2026)
 Table 19. Global Penem APIs and Intermediates Sales by Region (Tons), 2027–2032
 Table 20. Global Penem APIs and Intermediates Sales Market Share by Region (2027–2032)
 Table 21. Global Penem APIs and Intermediates Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Penem APIs and Intermediates Revenue Market Share by Region (2021–2026)
 Table 23. Global Penem APIs and Intermediates Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Penem APIs and Intermediates Revenue Market Share by Region (2027–2032)
 Table 25. North America Penem APIs and Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Penem APIs and Intermediates Sales by Country (Tons), 2021–2026
 Table 27. North America Penem APIs and Intermediates Sales by Country (Tons), 2027–2032
 Table 28. North America Penem APIs and Intermediates Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Penem APIs and Intermediates Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Penem APIs and Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Penem APIs and Intermediates Sales by Country (Tons), 2021–2026
 Table 32. Europe Penem APIs and Intermediates Sales by Country (Tons), 2027–2032
 Table 33. Europe Penem APIs and Intermediates Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Penem APIs and Intermediates Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Penem APIs and Intermediates Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Penem APIs and Intermediates Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Penem APIs and Intermediates Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Penem APIs and Intermediates Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Penem APIs and Intermediates Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Penem APIs and Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Penem APIs and Intermediates Sales by Country (Tons), 2021–2026
 Table 42. Latin America Penem APIs and Intermediates Sales by Country (Tons), 2027–2032
 Table 43. Latin America Penem APIs and Intermediates Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Penem APIs and Intermediates Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Penem APIs and Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Penem APIs and Intermediates Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Penem APIs and Intermediates Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Penem APIs and Intermediates Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Penem APIs and Intermediates Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Penem APIs and Intermediates Sales (Tons) by Type (2021–2026)
 Table 51. Global Penem APIs and Intermediates Sales (Tons) by Type (2027–2032)
 Table 52. Global Penem APIs and Intermediates Sales Market Share by Type (2021–2026)
 Table 53. Global Penem APIs and Intermediates Sales Market Share by Type (2027–2032)
 Table 54. Global Penem APIs and Intermediates Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Penem APIs and Intermediates Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Penem APIs and Intermediates Revenue Market Share by Type (2021–2026)
 Table 57. Global Penem APIs and Intermediates Revenue Market Share by Type (2027–2032)
 Table 58. Global Penem APIs and Intermediates Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Penem APIs and Intermediates Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Penem APIs and Intermediates Sales (Tons) by Application (2021–2026)
 Table 61. Global Penem APIs and Intermediates Sales (Tons) by Application (2027–2032)
 Table 62. Global Penem APIs and Intermediates Sales Market Share by Application (2021–2026)
 Table 63. Global Penem APIs and Intermediates Sales Market Share by Application (2027–2032)
 Table 64. Global Penem APIs and Intermediates Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Penem APIs and Intermediates Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Penem APIs and Intermediates Revenue Market Share by Application (2021–2026)
 Table 67. Global Penem APIs and Intermediates Revenue Market Share by Application (2027–2032)
 Table 68. Global Penem APIs and Intermediates Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Penem APIs and Intermediates Price (US$/Kg) by Application (2027–2032)
 Table 70. Shenzhen Haibin Pharmaceutical Company Information
 Table 71. Shenzhen Haibin Pharmaceutical Description and Business Overview
 Table 72. Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Product
 Table 74. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
 Table 75. Hainan Haiyao Company Information
 Table 76. Hainan Haiyao Description and Business Overview
 Table 77. Hainan Haiyao Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. Hainan Haiyao Penem APIs and Intermediates Product
 Table 79. Hainan Haiyao Recent Developments/Updates
 Table 80. Qilu Antibiotics Pharmaceutical Company Information
 Table 81. Qilu Antibiotics Pharmaceutical Description and Business Overview
 Table 82. Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Product
 Table 84. Qilu Antibiotics Pharmaceutical Recent Developments/Updates
 Table 85. Zhejiang Hisun Pharmaceutical Company Information
 Table 86. Zhejiang Hisun Pharmaceutical Description and Business Overview
 Table 87. Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Product
 Table 89. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 90. Zhejiang Hisoar Pharmaceutical Company Information
 Table 91. Zhejiang Hisoar Pharmaceutical Description and Business Overview
 Table 92. Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Product
 Table 94. Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
 Table 95. Sun Pharmaceutical Company Information
 Table 96. Sun Pharmaceutical Description and Business Overview
 Table 97. Sun Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. Sun Pharmaceutical Penem APIs and Intermediates Product
 Table 99. Sun Pharmaceutical Recent Developments/Updates
 Table 100. Savior Lifetec Company Information
 Table 101. Savior Lifetec Description and Business Overview
 Table 102. Savior Lifetec Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. Savior Lifetec Penem APIs and Intermediates Product
 Table 104. Savior Lifetec Recent Developments/Updates
 Table 105. ACS Dobfar Company Information
 Table 106. ACS Dobfar Description and Business Overview
 Table 107. ACS Dobfar Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 108. ACS Dobfar Penem APIs and Intermediates Product
 Table 109. ACS Dobfar Recent Developments/Updates
 Table 110. Kopran Company Information
 Table 111. Kopran Description and Business Overview
 Table 112. Kopran Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 113. Kopran Penem APIs and Intermediates Product
 Table 114. Kopran Recent Developments/Updates
 Table 115. High Tech Pharm Company Information
 Table 116. High Tech Pharm Description and Business Overview
 Table 117. High Tech Pharm Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 118. High Tech Pharm Penem APIs and Intermediates Product
 Table 119. High Tech Pharm Recent Developments/Updates
 Table 120. Zhuhai United Laboratories Company Information
 Table 121. Zhuhai United Laboratories Description and Business Overview
 Table 122. Zhuhai United Laboratories Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 123. Zhuhai United Laboratories Penem APIs and Intermediates Product
 Table 124. Zhuhai United Laboratories Recent Developments/Updates
 Table 125. Cspc Holdings Company Information
 Table 126. Cspc Holdings Description and Business Overview
 Table 127. Cspc Holdings Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 128. Cspc Holdings Penem APIs and Intermediates Product
 Table 129. Cspc Holdings Recent Developments/Updates
 Table 130. Zhejiang Jiuzhou Pharmaceutical Company Information
 Table 131. Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
 Table 132. Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 133. Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Product
 Table 134. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
 Table 135. Jiangxi Fushine Pharmaceutical Company Information
 Table 136. Jiangxi Fushine Pharmaceutical Description and Business Overview
 Table 137. Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 138. Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Product
 Table 139. Jiangxi Fushine Pharmaceutical Recent Developments/Updates
 Table 140. Sichuan Xindi Pharmaceutical Company Information
 Table 141. Sichuan Xindi Pharmaceutical Description and Business Overview
 Table 142. Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 143. Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Product
 Table 144. Sichuan Xindi Pharmaceutical Recent Developments/Updates
 Table 145. Jeil Pharma Company Information
 Table 146. Jeil Pharma Description and Business Overview
 Table 147. Jeil Pharma Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 148. Jeil Pharma Penem APIs and Intermediates Product
 Table 149. Jeil Pharma Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Penem APIs and Intermediates Distributors List
 Table 153. Penem APIs and Intermediates Customers List
 Table 154. Penem APIs and Intermediates Market Trends
 Table 155. Penem APIs and Intermediates Market Drivers
 Table 156. Penem APIs and Intermediates Market Challenges
 Table 157. Penem APIs and Intermediates Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Penem APIs and Intermediates
 Figure 2. Global Penem APIs and Intermediates Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Penem APIs and Intermediates Market Share by Type: 2025 & 2032
 Figure 4. APIs Product Picture
 Figure 5. Intermediates Product Picture
 Figure 6. Global Penem APIs and Intermediates Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Penem APIs and Intermediates Market Share by Application: 2025 & 2032
 Figure 8. Meropenem
 Figure 9. Imipenem
 Figure 10. Biapenem
 Figure 11. Ertapenem
 Figure 12. Others
 Figure 13. Global Penem APIs and Intermediates Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Penem APIs and Intermediates Market Size (US$ Million), 2021–2032
 Figure 15. Global Penem APIs and Intermediates Sales (Tons), 2021–2032
 Figure 16. Global Penem APIs and Intermediates Average Price (US$/Kg), 2021–2032
 Figure 17. Penem APIs and Intermediates Report Years Considered
 Figure 18. Penem APIs and Intermediates Sales Share by Manufacturers in 2025
 Figure 19. Global Penem APIs and Intermediates Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Penem APIs and Intermediates Players: Market Share by Revenue in Penem APIs and Intermediates in 2025
 Figure 21. Penem APIs and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Penem APIs and Intermediates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Penem APIs and Intermediates Sales Market Share by Country (2021–2032)
 Figure 24. North America Penem APIs and Intermediates Revenue Market Share by Country (2021–2032)
 Figure 25. United States Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Penem APIs and Intermediates Sales Market Share by Country (2021–2032)
 Figure 28. Europe Penem APIs and Intermediates Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Penem APIs and Intermediates Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Penem APIs and Intermediates Revenue Market Share by Region (2021–2032)
 Figure 36. China Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Penem APIs and Intermediates Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Penem APIs and Intermediates Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Penem APIs and Intermediates Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Penem APIs and Intermediates Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Penem APIs and Intermediates Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Penem APIs and Intermediates by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Penem APIs and Intermediates by Type (2021–2032)
 Figure 56. Global Penem APIs and Intermediates Price (US$/Kg) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Penem APIs and Intermediates by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Penem APIs and Intermediates by Application (2021–2032)
 Figure 59. Global Penem APIs and Intermediates Price (US$/Kg) by Application (2021–2032)
 Figure 60. Penem APIs and Intermediates Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc